Non-Invasive Prenatal Testing (NIPT) offered by Natera is a screening method used to assess the risk of specific chromosomal conditions in a developing fetus. The timeframe for receiving results varies depending on factors such as clinic workload, sample quality, and laboratory processing time.
Timely results provide expectant parents with valuable information for informed decision-making regarding their pregnancy. This knowledge empowers them to plan for potential challenges and connect with appropriate support services. Advances in genetic screening technologies have significantly reduced the waiting period for these crucial insights compared to traditional methods.